A
MYGN icon

AlphaQuest’s Myriad Genetics MYGN Stock Holding History

AlphaQuest’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,381
Closed -$57.7K – 1305
2025
Q4 		$57.7K Buy
9,381
+6,768
+259% +$49.1K ﹤0.01% 1907
2025
Q3 		$18.9K Hold
2,613
– – ﹤0.01% 2102
2025
Q2 		$13.9K Sell
2,613
-28,493
-92% -$168K ﹤0.01% 1829
2025
Q1 		$276K Buy
31,106
+28,465
+1,078% +$342K 0.03% 820
2024
Q4 		$36.2K Sell
2,641
-5,360
-67% -$98.9K ﹤0.01% 1351
2024
Q3 		$219K Buy
8,001
+2,697
+51% +$73K 0.02% 1036
2024
Q2 		$130K Buy
5,304
+5,255
+10,724% +$115K 0.02% 868
2024
Q1 		$1.04K Buy
+49
New +$1.05K ﹤0.01% 1397

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AlphaQuest's MYGN Position: Q1 2026 in Review

AlphaQuest sold out of Myriad Genetics (MYGN) in Q1 2026, closing a stake of 9,381 shares — an estimated $57.7K sold.

AlphaQuest first reported a position in MYGN in Q1 2024 and held it in 8 quarters. The position peaked at $276K in Q1 2025. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • AlphaQuest reported no remaining Myriad Genetics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,381 Myriad Genetics shares in Q1 2026, an estimated $57.7K.
  • AlphaQuest first reported a position in Myriad Genetics in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Myriad Genetics position peaked at $276K in Q1 2025.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.